RBBP4 Enhances Platinum Chemo Resistance in Lung Adenocarcinoma

BACKGROUND: The majority of lung cancers are adenocarcinomas, with the proportion being 40%. The patients are mostly diagnosed in the middle and late stages with metastasis and easy recurrence, which poses great challenge to the treatment and prognosis. Platinum-based chemotherapy is a primary treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nianwu, Wang, Wei, Mao, Wenli, Kuerbantayi, Nazuke, Jia, Nuan, Chen, Yan, Zhou, Fang, Yin, Li, Wang, Yukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811416/
https://www.ncbi.nlm.nih.gov/pubmed/33506032
http://dx.doi.org/10.1155/2021/6905985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811416/
https://www.ncbi.nlm.nih.gov/pubmed/33506032
http://dx.doi.org/10.1155/2021/6905985

Ejemplares similares